Psyence Biomedical LTD.: Form 20-F for the period ended Mar 31, 2026
Filed with the SEC on Jun 22, 2026 and accepted by EDGAR at Jun 22, 2026, 20:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Shares outstanding | At period end2026-03-31 | 2,293,277 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001213900-26-070607. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.